Pathway to introducing a maternal RSV vaccine in Kenya
Starting on:
Sep 24, 2026
Ending on:
Sep 24, 2026
Moderator(s):
Venue:
KWTRP Kilifi Campus
Max Credits:
3 Points

Provider:
KEMRI-WELLCOME TRUST RESEARCH PROGRAMME
Claim Points

Pathway to introducing a maternal RSV vaccine in Kenya

Starting on:
Sep 24, 2026
Ending on:
Sep 24, 2026
Venue:
KWTRP Kilifi Campus

Description

Special scientific seminar

Objectives

Pathway to introducing a maternal RSV vaccine in Kenya

Presenters

  1. Prof. Fred Were
    Prof Fredrick Were, a Professor of Perinatal & Neonatal Medicine at School of Medicine, University of Nairobi. He is also the Chief Executive Director, Kenya Paediatric Research Consortium [Keprecon] and the chair Kenya National Immunization Technical Advisory Group (KENITAG)
    UON, KEPRECON, KENITAG

Search For CPD Activity